Clinic
Navarro Hospital LP
Navarro Hospital LP was paid $7.32M by Medicaid between Jan 2020 and Nov 2024, across 80 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoNAVARRO HOSPITAL LP
CORSICANA, TX 75110
CORSICANA, TX 75110
33aNPI1144274226assigned 05/21/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$7.32M
24GClaims103,220
24DCodes billed80
24AFirst – last monthJan 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#63 of 320
Median peer was paid$205K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,394 | $95K | |
| 2021 | 21,607 | $1.23M | |
| 2022 | 31,270 | $2.14M | |
| 2023 | 30,960 | $2.61M | |
| 2024incomplete | 17,989 | $1.25M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 10,468 | 10,022 | $2.68M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 4,978 | 4,668 | $1.59M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.5% | 2,481 | 2,380 | $479K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.8% | 8,099 | 7,789 | $425K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 1,162 | 1,076 | $360K |
| 87430 | 4.4% | 11,821 | 11,473 | $323K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.2% | 5,164 | 4,939 | $309K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,226 | 1,181 | $231K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,638 | 1,370 | $92K |
| 87428 | 1.2% | 4,440 | 4,309 | $88K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,107 | 1,077 | $71K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,567 | 1,406 | $68K |
68 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 422 | $65K |
| 80053 | Comprehensive metabolic panel | <1% | 7,118 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,154 | $53K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 773 | $48K |
| 87807 | <1% | 1,810 | $47K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 722 | $42K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 252 | $37K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 732 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 621 | $31K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,522 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 42 | $16K |
| 81001 | <1% | 4,957 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,182 | $12K |
| 80061 | Lipid panel | <1% | 1,352 | $12K |
| 84484 | <1% | 1,799 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,431 | $10K |
| 83880 | <1% | 457 | $8K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 122 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 598 | $8K |
| 84703 | <1% | 977 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 114 | $7K |
| 85027 | <1% | 476 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 895 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 971 | $5K |
| 83690 | <1% | 929 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 114 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 55 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $3K |
| 83735 | <1% | 670 | $2K | |
| 82550 | <1% | 662 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 44 | $2K |
| 83655 | <1% | 71 | $2K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 21 | $2K |
| 82607 | <1% | 158 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 131 | $1K |
| 83605 | <1% | 267 | $1K | |
| 82728 | <1% | 126 | $1K | |
| 85610 | <1% | 591 | $1K | |
| 84439 | <1% | 53 | $960.55 | |
| 85730 | <1% | 368 | $960.44 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 40 | $871.67 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 40 | $762.97 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 364 | $721.97 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 71 | $677.15 |
| 83550 | <1% | 97 | $595.48 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 99 | $554.18 |
| 87040 | <1% | 145 | $503.65 | |
| 87186 | <1% | 204 | $495.96 | |
| 83540 | <1% | 105 | $458.52 | |
| 87088 | <1% | 153 | $358.54 | |
| 87081 | <1% | 38 | $219.77 | |
| 86901 | <1% | 61 | $151.16 | |
| 86900 | <1% | 61 | $151.15 | |
| 82043 | <1% | 38 | $122.22 | |
| 94664 | <1% | 27 | $108.72 | |
| 59025 | Fetal non-stress test | <1% | 12 | $84.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 15 | $67.30 |
| 85379 | <1% | 13 | $26.94 | |
| 80164 | <1% | 12 | $24.72 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,296 | $6.89 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 28 | $0.02 |
| J2704 | Injection, propofol, 10 mg | 0% | 220 | $0.00 |
| 82962 | 0% | 740 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 92 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 107 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 176 | $0.00 |
| 74018 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR, DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.